CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 82.12% of retail investor accounts lose money when trading CFDs. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money

Welcome to Capital.com. The products and services listed on this website are not available to US residents.

Trade DOCMORRIS AG ORD - DOCM CFD

19.45
3.99%
0.20
Low: 18.8
High: 20.55
Market Trading Hours* (UTC) Open now
Closes on Thursday at 16:20

Mon - Fri: 08:00 - 16:20

  • Summary
  • Historical Data
Trading сonditions
Spread 0.20
Long position overnight fee

Long position overnight funding adjustment


Margin. Your investment $1,000.00
Overnight funding adjustment -0.012165 %
Charges from full value of position ($-2.31)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
-0.012165%
Short position overnight fee

Short position overnight funding adjustment


Margin. Your investment $1,000.00
Overnight funding adjustment -0.010057 %
Charges from full value of position ($-1.91)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
-0.010057%
Overnight fee time 22:00 (UTC)
Min traded quantity 1
Currency CHF
Margin 5.00%
Stock exchange Switzerland
Commission on trade 0%

Key Stats
Prev. Close 18.8
Open 19.05
1-Year Change -75.69%
Day's Range 18.8 - 20.55
  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
Jan 8, 2025 18.80 0.05 0.27% 18.75 19.00 17.95
Jan 7, 2025 18.85 -0.05 -0.26% 18.90 19.20 18.15
Jan 6, 2025 18.60 -1.05 -5.34% 19.65 19.85 18.10
Jan 3, 2025 19.75 0.05 0.25% 19.70 20.05 19.35
Dec 30, 2024 19.95 -0.25 -1.24% 20.20 20.75 19.20
Dec 27, 2024 20.55 -0.10 -0.48% 20.65 21.20 20.05
Dec 23, 2024 19.80 0.20 1.02% 19.60 20.35 18.95
Dec 20, 2024 19.75 0.10 0.51% 19.65 20.15 19.45
Dec 19, 2024 19.70 0.20 1.03% 19.50 20.55 19.50
Dec 18, 2024 20.10 -1.45 -6.73% 21.55 21.95 19.00
Dec 17, 2024 23.15 -0.70 -2.94% 23.85 24.35 22.85
Dec 16, 2024 24.20 0.05 0.21% 24.15 24.85 23.45
Dec 13, 2024 24.60 -1.40 -5.38% 26.00 26.05 24.05
Dec 12, 2024 26.15 0.70 2.75% 25.45 26.50 25.45
Dec 11, 2024 25.95 0.50 1.96% 25.45 26.35 25.25
Dec 10, 2024 25.25 -0.90 -3.44% 26.15 26.15 25.25
Dec 9, 2024 25.70 -1.45 -5.34% 27.15 27.50 24.85
Dec 6, 2024 28.00 2.05 7.90% 25.95 28.05 25.95
Dec 5, 2024 26.25 -2.25 -7.89% 28.50 28.50 25.45
Dec 4, 2024 27.85 -0.20 -0.71% 28.05 28.85 27.65

Start a global, multi-asset portfolio with an award-winning platform

Desktop

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
  • 2:1
  • 3:1
  • 5:1
  • 10:1
  • 20:1
Leverage
20:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long

For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

ZUR ROSE GROUP N Company profile

About Zur Rose Group AG

Zur Rose Group AG is a Switzerland-based company engaged in the drug distribution sector. The Company focuses on the wholesale trade of medicines, as well as operation of a mail-order pharmacy. The Company's activities are divided into two business segments: Zur Rose and DocMorris. The Zur Rose division includes wholesale business and provides drugs to medical doctors, health insurance companies, hospitals and healthcare companies, among others. The DocMorris division manages the mail-order business for drug retail. The Company operates in Switzerland, Germany and the Netherlands through a number of subsidiaries, such as Zur Rose Suisse AG, Zur Rose Pharma GmbH, BlueCare AG, DocMorris NV, Eurapon Pharmahandel GmbH and Vitalsana BV.

Financial summary

BRIEF: For the fiscal year ended 31 December 2021, Zur Rose Group AG revenues increased 17% to SF1.73B. Net loss increased 66% to SF225.7M. Revenues reflect Germany segment increase of 25% to SF1.02B, Switzerland segment increase of 5% to SF620.2M, Germany segment increase of 25% to SF1.02B, Switzerland segment increase of 5% to SF620.2M. Higher net loss reflects Marketing and acquisition expenses increase of 96% to SF118.8M (expense).

Equity composition

11/2018 rights issue, adj. fct. 1.05607, new shares offered 2665476 (late adjustment from e-mail)

Industry: Drug Retailers (NEC)

Walzmühlestrasse 49
FRAUENFELD
THURGAU 8500
CH

People also watch

US100

21,128.50 Price
-0.090% 1D Chg, %
Long position overnight fee -0.0233%
Short position overnight fee 0.0011%
Overnight fee time 22:00 (UTC)
Spread 7.0

Gold

2,675.21 Price
+0.400% 1D Chg, %
Long position overnight fee -0.0165%
Short position overnight fee 0.0083%
Overnight fee time 22:00 (UTC)
Spread 0.30

BTC/USD

92,405.25 Price
-2.060% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 22:00 (UTC)
Spread 50.00

XRP/USD

2.26 Price
-2.850% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 22:00 (UTC)
Spread 0.01128

Still looking for a broker you can trust?

Join the 660,000+ traders worldwide that chose to trade with Capital.com

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading